Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-039405

Director acquired 2,550 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ekman Lars · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-06-26 Grant or award : show line 1 in the form +2,550 12,300 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-06-26 Grant or award : show line 2 in the form Stock Option (Right to Buy) +4,250 $76.58 2030-06-26 4,250 4,250 D
Loading xslF345X03/doc4.xml…